BTI
TAK icon

Blue Trust Inc’s Takeda Pharmaceutical TAK Stock Holding History

Blue Trust Inc’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
9,807
+3,395
+53% +$56.2K ﹤0.01% 872
2026
Q1 		$119K Sell
6,412
-5,943
-48% -$104K ﹤0.01% 950
2025
Q4 		$193K Sell
12,355
-1,626
-12% -$23.2K ﹤0.01% 791
2025
Q3 		$205K Sell
13,981
-127
-0.9% -$1.89K ﹤0.01% 795
2025
Q2 		$218K Buy
14,108
+4,383
+45% +$64.8K ﹤0.01% 738
2025
Q1 		$145K Sell
9,725
-625
-6% -$8.76K ﹤0.01% 838
2024
Q4 		$137K Sell
10,350
-1,009
-9% -$13.9K ﹤0.01% 791
2024
Q3 		$147K Buy
11,359
+5,879
+107% +$83.4K ﹤0.01% 1017
2024
Q2 		$76.1K Buy
5,480
+2,330
+74% +$30.8K ﹤0.01% 1074
2024
Q1 		$43.8K Sell
3,150
-2,687
-46% -$39.1K ﹤0.01% 958
2023
Q4 		$91K Buy
5,837
+2,782
+91% +$39.5K ﹤0.01% 716
2023
Q3 		$48K Buy
3,055
+446
+17% +$6.9K ﹤0.01% 863
2023
Q2 		$43K Sell
2,609
-2,420
-48% -$39.7K ﹤0.01% 749
2023
Q1 		$78K Sell
5,029
-2,319
-32% -$36.9K ﹤0.01% 850
2022
Q4 		$95K Buy
7,348
+3,650
+99% +$51K ﹤0.01% 690
2022
Q3 		$52K Buy
3,698
+1,338
+57% +$18.6K ﹤0.01% 737
2022
Q2 		$34K Buy
+2,360
New +$33.7K ﹤0.01% 804

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Blue Trust Inc's TAK Position: Q2 2026 in Review

Blue Trust Inc increased its Takeda Pharmaceutical (TAK) stake by 53% in Q2 2026, buying an estimated $56.2K and bringing the position to 9,807 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #872.

Blue Trust Inc first reported a position in TAK in Q2 2022 and has held it in 17 quarters since. The position peaked at $218K in Q2 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Blue Trust Inc held 9,807 shares of Takeda Pharmaceutical worth $157K as of Q2 2026.
  • Blue Trust Inc bought 3,395 Takeda Pharmaceutical shares in Q2 2026, an estimated $56.2K.
  • Takeda Pharmaceutical made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #872 holding.
  • Blue Trust Inc first reported a position in Takeda Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Takeda Pharmaceutical position peaked at $218K in Q2 2025.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.